- G-8 to work with intergovernmental organizations to respond constructively to requests by African developing countries without manufacturing capacities with regard to the use of the flexibilities referenced in the WTO Doha Declaration on TRIPS and Public Health, while respecting WTO obligations; and with the pharmaceutical industry to consider supporting local production of HIV/AIDS pharmaceuticals through voluntary licenses and laboratory capacities that meet international standards and strengthen regulatory, certification and training institutes.
- G-8 countries also committed to continue to scale up efforts towards the goal of universal access, the MDGs for fighting HIV/AIDS, malaria and tuberculosis as well as strengthening of health systems by providing at least a projected $60 billion over the coming years.
- No new targets on TRIPS - Provide at least $60 billion over the coming years towards fighting HIV/AIDS, malaria and tuberculosis and strengthening of health systems.
- For progress on TRIPS, see Doha Declaration on TRIPS Agreement and Public Health - Data not available on progress in delivering the promised $60 billion
It is difficult to measure a gap or data is not available.
It is not clear whether the $60 billion is additional to other ODA and health commitments.